(Q34631320)

3 August 2017

1 reference

title

Critical evaluation of prognostic factors in childhood asthma (English)

1 reference

3 August 2017

0 references

Van Bever HP

1

1 reference

3 August 2017

Desager KN

series ordinal

2

1 reference

3 August 2017

Hagendorens M

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Pediatric Allergy & Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

77-83

1 reference

The natural history of asthma.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Natural history of childhood asthma. 20-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Wheezing in early life and asthma at school age: predictors of symptom persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Influence of a positive family history and associated allergic diseases on the natural course of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Respiratory status and allergy after bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Antibiotic use in early childhood and the development of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Asthma and persistent wheeze in the Harvard six cities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Asthma: from childhood to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

The natural history of asthma in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Outcome of asthma: longitudinal changes in lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Serum eosinophilic cationic protein may predict clinical course of wheezing in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Can we predict which wheezy infants will continue to wheeze?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

Bronchial hyperresponsiveness, atopy, airway inflammation, and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

A clinical index to define risk of asthma in young children with recurrent wheezing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Interleukin-4, soluble CD23 and interferon-gamma levels in serum during the first 18 months of life

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

A prospective 12-year follow-up study of children with wheezy bronchitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

The course and prognosis of different forms of chronic airways obstruction in a sample from the general population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Response of normal infants to inhaled histamine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Bronchial responsiveness and lung function in recurrently wheezy infants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Bronchial responsiveness in the neonatal period as a risk factor for wheezing in infancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Prognosis of asthma from childhood to adulthood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Childhood asthma and lung function in mid-adult life

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2002.00093.X

7 January 2021

10.1034/J.1399-3038.2002.00093.X

Identifiers

DOI

1 reference

3 August 2017

1 reference